Clinical Trials
3 trialsNCT05634954 2025-10-23
Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer
GE Healthcare
Phase 1 Withdrawn
NCT03121989 2023-03-30
LABC
Sunnybrook Health Sciences Centre
Phase 1 Withdrawn
NCT03203616 2018-11-29
KIARA
Jules Bordet Institute
Phase 2 Withdrawn